Case Study: Praxis Precision Medicines

Praxis Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for central nervous systems (CNS) disorders characterized by neuronal excitation-inhibition imbalance. The needs of patients with CNS disorders are devastatingly urgent. The mission at Praxis is to help patients by delivering life-altering treatments faster and more effectively than has ever been done before - and to do it again and again.

We've brought their brand to the world and their purpose to life from steath mode to IPO and beyond.